Patients with certain genetic profiles may experience stronger appetite suppression with oral semaglutide, while others benefit more from injectable formulations or combination therapies like GLP-Squared
Adjustment for age, parity, ethnicity, income, occupation, education and preexisting comorbidity did not alter the findings substantially (adjusted HR 0.96 [95% CI 0.83-1.12]), nor did the sensitivity analyses produce results that supported a significant association
Ozempic -semaglutide injection, solution
They are best kept occasional
Molecular characterisation of glutamate dehydrogenase gene defects in Japanese patients with congenital hyperinsulinism/hyperammonaemia
For women with polycystic ovary syndrome (PCOS), weight loss can paradoxically improve menstrual regularity